|
PLX Protalix Biotherapeutics Inc 1006281 |
| Balance Sheet |
|
Current Assets
|
47,853,000 |
|
Assets
|
61,563,000 |
|
Current Liabilities
|
24,220,000 |
|
Liabilities
|
29,126,000 |
|
Equity
|
32,437,000 |
|
Shares Out
|
80,572,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
4,683,000 |
|
Investing Cash Flow
|
19,541,000 |
| Market Analysis |
Market Cap
|
177,257,567 |
|
Price
|
2.20 |
|
BVPS
|
0.44 |
|
PB
|
5.17 |
|
EPS
|
-0.08 |
|
PS
|
1.13 |
|
FCF
|
24,224,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PLX documents filed with the SEC.
PLX Filings
Clear
